Dr. Jeffrey Mattes, psychiatrist in Princeton, New Jersey speaks about drug interaction warnings that appear during electronic prescribing and how these warnings may be influenced by drug company promotion.

This interview is part of a series covering the 2018 ASCP Annual Meeting.

Here is the summary of this interview:

• Drug interaction warnings are issued by drug compendia, which claim to be independent of drug company influence. However, this has been recently questioned and there are examples that point to drug warnings being motivated by drug company promotion.
• Clinicians should meet these warnings with skepticism and be aware of this potential.

Resources

• Access a text version of this episode here
• Learn more about our memberships here